D-0120

DRUG5 trials

Sponsors

InventisBio Co., Ltd

Conditions

GoutHealthy VolunteersHyperuricemiaHyperuricemia or Gout

Phase 1

D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers

CompletedNCT03291782

InventisBio Co., LtdGout

Start: 2017-09-13End: 2018-08-06Updated: 2018-12-19

D-0120 Safety and PK/PD Study in China

CompletedNCT03923868

InventisBio Co., LtdHyperuricemia or Gout

Start: 2019-04-18End: 2021-12-31Updated: 2022-05-06

Phase I Study of D-0120 to Evaluate Safety and PK/PD Study in Healthy Volunteers

CompletedNCT04097405

InventisBio Co., LtdHealthy Volunteers

Start: 2019-09-18End: 2020-11-18Updated: 2021-02-10

Phase 2

Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients

CompletedNCT05504083

InventisBio Co., LtdHyperuricemia

Start: 2022-09-28End: 2024-05-18Updated: 2024-10-15

Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout

CompletedNCT05665699

InventisBio Co., LtdGout

Start: 2023-04-17End: 2025-12-30Updated: 2026-07-09